For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
The price of Pediatrix Medical Group Inc (NYSE: MD) closed at $8.50 in the last session, down -6.08% from day before closing price of $9.05. In other words, the price has decreased by -$6.08 from its previous closing price. On the day, 1.1 million shares were traded. MD stock price reached its highest trading level at $9.02 during the session, while it also had its lowest trading level at $8.32.
Ratios:
We take a closer look at MD’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.19 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 5.36. For the most recent quarter (mrq), Quick Ratio is recorded 1.20 and its Current Ratio is at 2.06. In the meantime, Its Debt-to-Equity ratio is 0.91 whereas as Long-Term Debt/Eq ratio is at 0.91.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, SVB Leerink on September 27, 2021, initiated with a Mkt Perform rating and assigned the stock a target price of $29.
Deutsche Bank Downgraded its Hold to Sell on October 19, 2020, whereas the target price for the stock was revised from $20 to $12.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 14 ’23 when Swift James D sold 5,764 shares for $9.58 per share. The transaction valued at 55,219 led to the insider holds 90,874 shares of the business.
Moore Mary Ann E sold 1,150 shares of MD for $11,063 on Dec 14 ’23. The EVP, General Counsel & Sec now owns 15,730 shares after completing the transaction at $9.62 per share. On Dec 14 ’23, another insider, Moore Mary Ann E, who serves as the EVP, General Counsel & Sec of the company, sold 970 shares for $9.62 each. As a result, the insider received 9,331 and left with 81,385 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MD now has a Market Capitalization of 715251200 and an Enterprise Value of 1291972480. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.36 while its Price-to-Book (P/B) ratio in mrq is 0.74. Its current Enterprise Value per Revenue stands at 0.648 whereas that against EBITDA is 6.659.
Stock Price History:
The Beta on a monthly basis for MD is 1.59, which has changed by -0.3321033 over the last 52 weeks, in comparison to a change of 0.2537824 over the same period for the S&P500. Over the past 52 weeks, MD has reached a high of $15.02, while it has fallen to a 52-week low of $7.70. The 50-Day Moving Average of the stock is -7.81%, while the 200-Day Moving Average is calculated to be -20.51%.
Shares Statistics:
According to the various share statistics, MD traded on average about 709.35K shares per day over the past 3-months and 623340 shares per day over the past 10 days. A total of 84.12M shares are outstanding, with a floating share count of 83.32M. Insiders hold about 0.95% of the company’s shares, while institutions hold 97.90% stake in the company. Shares short for MD as of 1713139200 were 4602543 with a Short Ratio of 6.49, compared to 1710460800 on 4034526. Therefore, it implies a Short% of Shares Outstanding of 4602543 and a Short% of Float of 7.79.
Earnings Estimates
Pediatrix Medical Group Inc (MD) is currently under the scrutiny of 8.0 analysts, each contributing to the ongoing evaluation of its stock.On average, analysts expect EPS of $0.34 for the current quarter, with a high estimate of $0.37 and a low estimate of $0.3, while EPS last year was $0.39. The consensus estimate for the next quarter is $0.34, with high estimates of $0.4 and low estimates of $0.31.
Analysts are recommending an EPS of between $1.31 and $1.16 for the fiscal current year, implying an average EPS of $1.24. EPS for the following year is $1.27, with 8.0 analysts recommending between $1.34 and $1.12.
Revenue Estimates
According to 8 analysts, the current quarter’s revenue is expected to be $507.78M. It ranges from a high estimate of $510.59M to a low estimate of $503.6M. As of the current estimate, Pediatrix Medical Group Inc’s year-ago sales were $500.58MFor the next quarter, 8 analysts are estimating revenue of $516.95M. There is a high estimate of $526.88M for the next quarter, whereas the lowest estimate is $510.4M.
A total of 8 analysts have provided revenue estimates for MD’s current fiscal year. The highest revenue estimate was $2.07B, while the lowest revenue estimate was $2.01B, resulting in an average revenue estimate of $2.03B. In the same quarter a year ago, actual revenue was $1.99BBased on 8 analysts’ estimates, the company’s revenue will be $2.1B in the next fiscal year. The high estimate is $2.16B and the low estimate is $2.07B.
